Research published in peer-reviewed journals documents that the copper tripeptide influences the expression of an estimated 4,000+ genes, including key regulators of inflammation, collagen synthesis, matrix metalloproteinase activity, and antioxidant enzyme production
GIP receptor activation Glucose-dependent insulinotropic polypeptide (GIP) is the second receptor target, similar to tirzepatide (Mounjaro, Zepbound): Effects: Enhances insulin release from the pancreas Works synergistically with GLP-1 for appetite control May influence fat storage and energy balance Improves glucose regulation Tirzepatide's success as a dual GLP-1/GIP agonist demonstrated that adding GIP to GLP-1 enhances weight loss beyond GLP-1 alone
When stopping, your doctor will guide you to step down gradually through lower doses rather than stopping cold, which helps your body adjust more smoothly
Together, we can design a personalized weight loss plan that aligns with your health goals and supports your long-term success
